延长保质期对血小板可用性的影响:库存管理建模研究的结果
Veronika Brixner1, Marcia Cardoso2, Erik Spaepen3
1German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, Frankfurt am Main, Germany.
概括
在德国延长血小板缩剂 (PC) 的保质期可以显著减少短缺. 6或7天的保质期,再加上优化生产,几乎可以消除PC不可用性,即使对于罕见的血型.
科学领域:
- 输血医学 输血医学
- 血液学 血液学 血液学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 在德国,血小板度 (PC) 的需求正在上升,而全血捐献量已经下降.
- 目前PC的保质期为4天,可延长至5天,这有助于减少PC的可用性.
- 短暂的PC保质期对维持充足的血液供应构成了挑战.
研究的目的:
- 评估延长血小板度 (PC) 保存期对PC短缺的影响.
- 为了告知血液服务和监管机构关于更长PC保质期的好处.
主要方法:
- 使用来自德国红十字会输血服务的PC生产和交付数据开发了一个数学模拟模型.
- 用2.2年的数据集进行蒙特卡洛库存管理模拟,以评估PC短缺.
- 该模型分析了日常库存,发布时的PC年龄,过期的单位和短缺率.
主要成果:
- 增加PC保质期和/或过度生产率有效降低了短缺率.
- 将保质期延长到6或7天,过度生产率为20%,可以将短缺从2.8%降至0.2%.
- 将保质期延长到6或7天几乎消除了短缺,包括罕见血型.
结论:
- 将血小板度 (PC) 的保质期延长到6或7天是一个可行的策略,可以显著提高PC的可用性.
- 这些发现支持血液服务机构和监管机构对PC保质期的政策变化.
- 优化PC生产并延长保质期,为输血短缺提供了一个强大的解决方案.
更多相关视频
12:40Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
28.6K
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
485
相关概念视频
Structure and Function of Platelets
988
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
988
Formation of the Platelet Plug
4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
